Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Andrew Lassman"'
Autor:
John V. Heymach, Patrick Y. Wen, Michael Prados, WKA Yung, Alice Chen, Kevin Camphausen, Lisa DeAngelis, Andrew Lassman, H. Ian Robins, Minesh Mehta, Tim Cloughesy, B. Nebiyou Bekele, Jun Liu, Hua-Kang Wu, Mark Gilbert, Hai Tran, Yuji Piao, John F. de Groot
Purpose: VEGF and infiltrating myeloid cells are known regulators of tumor angiogenesis and vascular permeability in glioblastoma. We investigated potential blood-based markers associated with radiographic changes to aflibercept, which binds VEGF and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ba4ea884f7fa65c6ce14e5cf4c92e6c
https://doi.org/10.1158/1078-0432.c.6519194
https://doi.org/10.1158/1078-0432.c.6519194
Autor:
John V. Heymach, Patrick Y. Wen, Michael Prados, WKA Yung, Alice Chen, Kevin Camphausen, Lisa DeAngelis, Andrew Lassman, H. Ian Robins, Minesh Mehta, Tim Cloughesy, B. Nebiyou Bekele, Jun Liu, Hua-Kang Wu, Mark Gilbert, Hai Tran, Yuji Piao, John F. de Groot
Supplementary Figure 1 from Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0800d1e19657b62848eda43f68aa9a4c
https://doi.org/10.1158/1078-0432.22442477.v1
https://doi.org/10.1158/1078-0432.22442477.v1
Autor:
Nimish A. Mohile, Hans Messersmith, Na Tosha Gatson, Andreas F. Hottinger, Andrew Lassman, Jordan Morton, Douglas Ney, Phioanh Leia Nghiemphu, Adriana Olar, Jeffery Olson, James Perry, Jana Portnow, David Schiff, Anne Shannon, Helen A. Shih, Roy Strowd, Martin van den Bent, Mateo Ziu, Jaishri Blakeley
Publikováno v:
Neuro Oncol
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(4), 403-426. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(4), 403-426. American Society of Clinical Oncology
Purpose To provide guidance to clinicians regarding therapy for diffuse astrocytic and oligodendroglial tumors in adults. Methods ASCO and the Society for Neuro-Oncology convened an Expert Panel and conducted a systematic review of the literature. Re
Autor:
Isabel Arrillaga-Romany, Andrew Lassman, Susan L. McGovern, Sabine Mueller, Louis B. Nabors, Martin van den Bent, Michael Vogelbaum, Joshua E. Allen, Allen S. Melemed, Rohinton S. Tarapore, Dewen Yang, Patrick Wen, Timothy Cloughsey
Publikováno v:
Cancer Research. 83:CT060-CT060
Background: H3 K27M-mutant diffuse midline glioma is a universally fatal malignancy primarily affecting children and young adults. While radiotherapy (RT) provides transient benefit, no effective systemic therapy is currently available and current st
Autor:
Ingo K. Mellinghoff, Brian Alexander, Donald Berry, Nicholas Blondin, Meredith Buxton, Webster Cavenee, Howard Colman, John de Groot, Macarena I. de la Fuente, Benjamin Ellingson, Gary Gordon, Emma M.V. Hyddmark, Mustafa Khasraw, Andrew Lassman, Eudocia Lee, Wenbin Li, Michael Lim, Tom Mikkelsen, Apoorva Nelli, James Perry, Erik Sulman, Kirk Tanner, Michael Weller, Patrick Y. Wen, Timothy Cloughesy
Publikováno v:
Cancer Research. 83:CT062-CT062
Background: GBM AGILE (Glioblastoma Adaptive, Global, Innovative Learning Environment) is a biomarker based, multi-arm, international, seamless Phase 2/3 Response Adaptive Randomization platform trial designed to rapidly identify experimental therapi
Autor:
Benjamin Ellingson, Patrick Y Wen, Susan Chang, Martin van den Bent, Michael Vogelbaum, Gang Li, Shanpeng Li, Jiyoon Kim, Gilbert Youssef, Wolfgang Wick, Andrew Lassman, Mark Gilbert, John de Groot, Michael Weller, Evanthia Galanis, Timothy Cloughesy
Publikováno v:
Neuro-Oncology. 24:vii172-vii173
Durable overall response rate (ORR) remains a meaningful endpoint in recurrent GBM; however, the target ORR for single arm recurrent GBM trials has not been based on historic information or tied to patient outcomes. The current study reviewed past tr
Autor:
Prabhjot S. Mundi, Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey, Kristina C. Guillan, Armaan Siddiquee, Daoqi You, Ronald Realubit, Charles Karan, Michael V. Ortiz, Eugene F. Douglass, Melissa Accordino, Suzanne Mistretta, Frances Brogan, Jeffrey N. Bruce, Cristina I. Caescu, Richard Carvajal, Katherine Crew, Guarionex Decastro, Mark Heaney, Brian Henick, Dawn Hershman, June Hou, Fabio Iwamoto, Joseph Jurcic, Ravi P. Kiran, Michael Kluger, Teri Kreisl, Nicole Lamanna, Andrew Lassman, Emerson Lim, Gulam A. Manji, Guy McKhann, James McKiernan, Alfred I. Neugut, Kenneth Olive, Todd Rosenblat, Gary K. Schwartz, Catherine Shu, Michael Sisti, Ana Tergas, Reena Vattakalam, Mary Welch, Sven Wenske, Jason D. Wright, Hanina Hibshoosh, Kevin M. Kalinsky, Mahalaxmi Aburi, Peter A. Sims, Mariano J. Alvarez, Andrew L. Kung, Andrea Califano
Publikováno v:
SSRN Electronic Journal.
Autor:
Eleonora F. Spinazzi, Michael G. Argenziano, Pavan S. Upadhyayula, Matei A. Banu, Justin A. Neira, Dominique M.O. Higgins, Peter B. Wu, Brianna Pereira, Aayushi Mahajan, Nelson Humala, Osama Al-Dalahmah, Wenting Zhao, Akshay V. Save, Deborah M. Boyett, Tamara Marie, Julia L Furnari, Tejaswi D. Sudhakar, Sylwia A. Stopka, Michael S. Regan, Vanessa Catania, Laura Good, Meenu Behl, Sachin Jambawalikar, Akiva Mintz, Angela Lignelli, Nathalie Y.R. Agar, Peter A. Sims, Mary Welch, Andrew Lassman, Fabio Iwamoto, Randy S. D’Amico, Jack Grinband, Peter Canoll, Jeffrey N. Bruce
Glioblastoma, the most common primary brain malignancy, is invariably fatal. Systemic chemotherapy is ineffective mostly because of drug delivery limitations. To overcome this, we devised an internalized pump-catheter system for direct chronic convec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e662be7b4518bea92e47e3dde561c23f
https://doi.org/10.1101/2021.12.04.21266935
https://doi.org/10.1101/2021.12.04.21266935
Autor:
Prabhjot S. Mundi, Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey, Kristina C. Guillan, Armaan Siddiquee, Daoqi You, Ronald Realubit, Charles Karan, Michael V. Ortiz, Melissa Accordino, Suzanne Mistretta, Frances Brogan, Jeffrey N. Bruce, Cristina I. Caescu, Richard Carvajal, Katherine Crew, Guarionex Decastro, Mark Heaney, Brian Henick, Dawn Hershman, June Hou, Fabio Iwamoto, Joseph Jurcic, Ravi P. Kiran, Michael Kluger, Teri Kreisl, Nicole Lamanna, Andrew Lassman, Emerson Lim, Gulam A. Manji, Guy McKhann, James McKiernan, Alfred Neugut, Kenneth Olive, Todd Rosenblat, Gary K. Schwartz, Catherine Shu, Michael Sisti, Ana Tergas, Reena Vattakalam, Mary Welch, Sven Wenske, Jason D. Wright, Hanina Hibshoosh, Kevin Kalinsky, Mahalaxmi Aburi, Peter A. Sims, Mariano J. Alvarez, Andrew L. Kung, Andrea Califano
Predicting tumor sensitivity to antineoplastics remains an elusive challenge, with no methods demonstrating predictive power. Joint analysis of tumors—from patients with distinct malignancies who had progressed on multiple lines of therapy—and dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d042b608599fa84e39415b1b49af898
https://doi.org/10.1101/2021.10.03.462951
https://doi.org/10.1101/2021.10.03.462951
Autor:
Patrick Y Wen, David A Reardon, Deborah Forst, Eudocia Lee, Teresa Daoud, Tamara Berthoud, Catalina Soare, Francisco Diaz-Mitoma, David E Anderson, Andrew Lassman, Fabio Iwamoto
Publikováno v:
Neuro-Oncology. 24:vii62-vii62
Cytomegalovirus (CMV) antigens have been reported in over 90% of GBMs. CD4+ and CD8+ T cells are most frequently directed against the gB and pp65 antigens, respectively, which are immunogenic targets in a CMV-based GBM immunotherapeutic. First-recurr